Orthopneumovirus

Last updated
Orthopneumovirus
Ijms-20-04657-g008.webp
Pneumovirus structure and genome
Respiratory syncytial virus 01.jpg
Transmission electron micrograph of Human orthopneumovirus
Virus classification OOjs UI icon edit-ltr.svg
(unranked): Virus
Realm: Riboviria
Kingdom: Orthornavirae
Phylum: Negarnaviricota
Class: Monjiviricetes
Order: Mononegavirales
Family: Pneumoviridae
Genus:Orthopneumovirus
Species

The genus Orthopneumovirus consists of pathogens that target the upper respiratory tract within their specific hosts. [1] Every orthopneumovirus is characterized as host-specific, and has a range of diseases involved with respiratory illness. Orthopneumoviruses can cause diseases that range from a less-severe upper-respiratory illness to severe bronchiolitis or pneumonia. Orthopneumoviruses are found among sheep, cows, and most importantly humans. In humans, the orthopneumovirus that specifically impacts infants and small children is known as human respiratory syncytial virus. [2]

Contents

Taxonomy

Genus Orthopneumovirus: species and their viruses [1] [3]
Genus Species Virus (Abbreviation)
OrthopneumovirusBovine orthopneumovirus Bovine respiratory syncytial virus (BRSV)
Human orthopneumovirus human respiratory syncytial virus A2 (HRSV-A2)
human respiratory syncytial virus B1 (HRSV-B1)
Murine orthopneumovirusmurine pneumonia virus (MPV)

Other viruses in this taxon include canine pneumovirus.

Characteristics

The genus Orthopneumovirus is included in the family Pneumoviridae . Orthopneumoviruses are found specifically in the members of the species Homo sapiens , Ovis aries , Capra aegagrus hircus , Bos primigenius , and the order Rodentia.[ citation needed ]

The most common pneumoviruses are as follows:[ citation needed ]

Homo sapiens : human respiratory syncytial virus

Bos primigenius : bovine respiratory syncytial virus

Rodentia : murine pneumonia virus

Symptoms

Mild symptoms may include rhinitis, coughing, and decreased appetite. More serious symptoms include wheezing, difficulty breathing, fever, bronchiolitis and pneumonia. [4]

Risk factors

Having a weak immune system and pre-existing conditions such as asthma can be leading factors in catching an orthopneumovirus. In elderly adults, having chronic heart or lung disease is also risk factor. Being in close proximity to a host who has been infected with an orthopneumovirus can also be a risk since most transmission happens via respiratory.[ citation needed ]

Diagnosis

Transmission of an infectious agent by another person or animal can be through blood, needles, blood transfusion, a mother to fetus, coughing, sneezing, saliva, or air transmission. Healthcare providers will determine the severity of the virus and possible treatment options. Healthcare providers will also decide if hospitalization is needed for more intense cases. [4] [5] [6]

Treatment

Treatment plans are not specific and are based upon a specific host's current symptoms. Pain relievers or nonsteroidal anti-inflammatory drugs such as acetaminophen or ibuprofen can be prescribed. Isolation is the first course of action for the infected host. In more serious cases hospitalization may be necessary and supplemental oxygen may be used to aid in oxygen intake. In severe viral detection, intubation and the use of a mechanical ventilation will be inserted as a breathing apparatus. [5]

Prevention

The best methods of prevention of orthopneumovirus infection are covering cough and sneezing to prevent transmission of possible pathogens. Isolating animals and humans that have a pneumovirus is the best way to prevent the virus from spreading. Molecular studies have been on the rise due to continuing materials and information obtained regarding recombinant DNA arrangements that might offer a foundation for vaccine development. Currently animals are able to receive vaccines specific to their virus strand. During cold and peak flu season, infants and small children have the option to receive monthly injections of small medication doses at a weak strength to help prevent virus/ host attachment. [7]

Cases

Human respiratory syncytial virus (HRSV) is the most known orthopneumovirus because of its direct correlation and importance in humans. RSV is the leading viral agent among pneumoviruses in pediatric upper respiratory diseases globally. New pneumoviruses have been discovered in the Netherlands among 28 children according to studies. Certain studies have isolated the children in hospitals to identify specific causes, contagion levels, and treatment options among those children. [2]

Related Research Articles

<span class="mw-page-title-main">Common cold</span> Common viral infection of the upper respiratory tract

The common cold or the cold is a viral infectious disease of the upper respiratory tract that primarily affects the respiratory mucosa of the nose, throat, sinuses, and larynx. Signs and symptoms may appear fewer than two days after exposure to the virus. These may include coughing, sore throat, runny nose, sneezing, headache, and fever. People usually recover in seven to ten days, but some symptoms may last up to three weeks. Occasionally, those with other health problems may develop pneumonia.

<i>Adenoviridae</i> Family of viruses

Adenoviruses are medium-sized, nonenveloped viruses with an icosahedral nucleocapsid containing a double-stranded DNA genome. Their name derives from their initial isolation from human adenoids in 1953.

<span class="mw-page-title-main">Bronchiolitis</span> Blockage of the small airways in the lungs due to a viral infection

Bronchiolitis is inflammation of the small airways in the lungs. Acute bronchiolitis is due to a viral infection usually affecting children younger than two years of age. Symptoms may include fever, cough, runny nose, wheezing, and breathing problems. More severe cases may be associated with nasal flaring, grunting, or the skin between the ribs pulling in with breathing. If the child has not been able to feed properly, signs of dehydration may be present.

<span class="mw-page-title-main">Respiratory syncytial virus</span> Species of a virus

Respiratory syncytial virus (RSV), also called human respiratory syncytial virus (hRSV) and human orthopneumovirus, is a common, contagious virus that causes infections of the respiratory tract. It is a negative-sense, single-stranded RNA virus. Its name is derived from the large cells known as syncytia that form when infected cells fuse.

<i>Human metapneumovirus</i> Species of virus

Human metapneumovirus is a negative-sense single-stranded RNA virus of the family Pneumoviridae and is closely related to the Avian metapneumovirus (AMPV) subgroup C. It was isolated for the first time in 2001 in the Netherlands by using the RAP-PCR technique for identification of unknown viruses growing in cultured cells. It is the second most common cause after respiratory syncytial virus (RSV) of lower respiratory infection in young children.

<span class="mw-page-title-main">Human parainfluenza viruses</span> Viruses that cause human parainfluenza

Human parainfluenza viruses (HPIVs) are the viruses that cause human parainfluenza. HPIVs are a paraphyletic group of four distinct single-stranded RNA viruses belonging to the Paramyxoviridae family. These viruses are closely associated with both human and veterinary disease. Virions are approximately 150–250 nm in size and contain negative sense RNA with a genome encompassing about 15,000 nucleotides.

Viral pneumonia is a pneumonia caused by a virus. Pneumonia is an infection that causes inflammation in one or both of the lungs. The pulmonary alveoli fill with fluid or pus making it difficult to breathe. Pneumonia can be caused by bacteria, viruses, fungi or parasites. Viruses are the most common cause of pneumonia in children, while in adults bacteria are a more common cause.

<span class="mw-page-title-main">Adenovirus infection</span> Medical condition

Adenovirus infection is a contagious viral disease, caused by adenoviruses, commonly resulting in a respiratory tract infection. Typical symptoms range from those of a common cold, such as nasal congestion, coryza and cough, to difficulty breathing as in pneumonia. Other general symptoms include fever, fatigue, muscle aches, headache, abdominal pain and swollen neck glands. Onset is usually two to fourteen days after exposure to the virus. A mild eye infection may occur on its own, combined with a sore throat and fever, or as a more severe adenoviral keratoconjunctivitis with a painful red eye, intolerance to light and discharge. Very young children may just have an earache. Adenovirus infection can present as a gastroenteritis with vomiting, diarrhoea and abdominal pain, with or without respiratory symptoms. However, some people have no symptoms.

<span class="mw-page-title-main">Gregory Prince</span>

Gregory Antone Prince is an American pathology researcher, businessman, author, social critic, and historian of the Latter Day Saint movement.

<i>Human coronavirus NL63</i> Species of virus

Human coronavirus NL63 (HCoV-NL63) is a species of coronavirus, specifically a Setracovirus from among the Alphacoronavirus genus. It was identified in late 2004 in patients in the Netherlands by Lia van der Hoek and Krzysztof Pyrc using a novel virus discovery method VIDISCA. Later on the discovery was confirmed by the researchers from the Rotterdam, the Netherlands The virus is an enveloped, positive-sense, single-stranded RNA virus which enters its host cell by binding to ACE2. Infection with the virus has been confirmed worldwide, and has an association with many common symptoms and diseases. Associated diseases include mild to moderate upper respiratory tract infections, severe lower respiratory tract infection, croup and bronchiolitis.

Aujeszky's disease, usually called pseudorabies in the United States, is a viral disease in swine that has been endemic in most parts of the world. It is caused by Suid herpesvirus 1 (SuHV-1). Aujeszky's disease is considered to be the most economically important viral disease of swine in areas where classical swine fever has been eradicated. Other mammals, such as cattle, sheep, goats, cats, dogs, and raccoons, are also susceptible. The disease is usually fatal in these animal species.

Palivizumab, sold under the brand name Synagis, is a monoclonal antibody produced by recombinant DNA technology used to prevent severe disease caused by respiratory syncytial virus (RSV) infections. It is recommended for infants at high-risk for RSV due to conditions such as prematurity or other medical problems including heart or lung diseases.

<span class="mw-page-title-main">Influenza</span> Infectious disease, often just "the flu"

Influenza, commonly known as "the flu", is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptoms begin from one to four days after exposure to the virus and last for about 2–8 days. Diarrhea and vomiting can occur, particularly in children. Influenza may progress to pneumonia, which can be caused by the virus or by a subsequent bacterial infection. Other complications of infection include acute respiratory distress syndrome, meningitis, encephalitis, and worsening of pre-existing health problems such as asthma and cardiovascular disease.

<span class="mw-page-title-main">Influenza-like illness</span> Medical diagnosis

Influenza-like illness (ILI), also known as flu-like syndrome or flu-like symptoms, is a medical diagnosis of possible influenza or other illness causing a set of common symptoms. These include fever, shivering, chills, malaise, dry cough, loss of appetite, body aches, and nausea, sneezing typically in connection with a sudden onset of illness. In most cases, the symptoms are caused by cytokines released by immune system activation, and are thus relatively non-specific.

<span class="mw-page-title-main">Robert M. Chanock</span> American pediatrician and virologist

Robert Merritt Chanock was an American pediatrician and virologist who made major contributions to the prevention and treatment of childhood respiratory infections in more than 50 years spent at the National Institute of Allergy and Infectious Diseases.

<i>Pneumoviridae</i> Family of viruses

Pneumoviridae is a family of negative-strand RNA viruses in the order Mononegavirales. Humans, cattle, and rodents serve as natural hosts. Respiratory tract infections are associated with member viruses such as human respiratory syncytial virus. There are five species in the family which are divided between the genera Metapneumovirus and Orthopneumovirus. The family used to be considered as a sub-family of Paramyxoviridae, but has been reclassified as of 2016.

<span class="mw-page-title-main">Brian R. Murphy</span>

Brian R. Murphy is an American virologist and former co-chief of the Laboratory of Infectious Diseases at the National Institute of Allergy and Infectious Disease.

Respiratory syncytial virus vaccine, or RSV vaccine, is a vaccine which prevents infection by respiratory syncytial virus. The RSV vaccines Arexvy (GSK), and Abrysvo (Pfizer), were both approved for medical use in the United States in May 2023.

Nirsevimab, sold under the brand name Beyfortus, is a human recombinant monoclonal antibody with activity against respiratory syncytial virus, or RSV for infants. It is under development by AstraZeneca and Sanofi. Nirsevimab is designed to bind to the fusion protein on the surface of the RSV virus.

Bovine respiratory syncytial virus (BRSV) is pneumovirus closely related to human respiratory syncytial virus (RSV) that is a common cause of respiratory disease in cattle, particularly calves. It is a negative-sense, single-stranded RNA virus that replicates in the cytoplasm of the cell. Similarly to other single-stranded RNA viruses, the genome of BRSV has a high mutation rate, which results in great antigenetic variation. Thus, BRSV can be split into four different subgroups based on antigen expression.

References

  1. 1 2 "ICTV Online (10th) Report".
  2. 1 2 Van Den Hoogen, Bernadette G.; De Jong, Jan C.; Groen, Jan; Kuiken, Thijs; De Groot, Ronald; Fouchier, Ron A.M.; Osterhaus, Albert D.M.E. (2001). "A newly discovered human pneumovirus isolated from young children with respiratory tract disease". Nature Medicine. 7 (6): 719–24. doi:10.1038/89098. PMC   7095854 . PMID   11385510.
  3. Amarasinghe, Gaya K.; Bào, Yīmíng; Basler, Christopher F.; Bavari, Sina; Beer, Martin; Bejerman, Nicolás; Blasdell, Kim R.; Bochnowski, Alisa; Briese, Thomas (2017-04-07). "Taxonomy of the order Mononegavirales: update 2017". Archives of Virology. 162 (8): 2493–2504. doi:10.1007/s00705-017-3311-7. ISSN   1432-8798. PMC   5831667 . PMID   28389807.
  4. 1 2 Bennett, Nicholas; Ellis, John; Bonville, Cynthia; Rosenberg, Helene; Domachowske, Joseph (2007). "Immunization strategies for the prevention of orthopneumovirus infections". Expert Review of Vaccines. 6 (2): 169–82. doi:10.1586/14760584.6.2.169. PMID   17408367. S2CID   44511976.
  5. 1 2 "Respiratory Syncytial Virus Infection (RSV)". Centers for Disease Control and Prevention . Retrieved 2019-06-03.
  6. McIntosh, K. M.; Chanock, R. M. (1985). "Respiratory Synoytial Virus". In Fields, Bernard N.; Knipe, David M.; Chanock, Robert M.; Hirsch, Martin S.; Melnick, Joseph L.; Monath, Thomas P.; Roizman, Bernard; Howley, Peter M.; Griffin, Diane E. (eds.). Fields Virology. New York: Raven Press. pp. 1285–304. ISBN   978-0-88167-552-8.
  7. Collins, Peter L. (1991). "The Molecular Biology of Human Respiratory Syncytial Virus (RSV) of the Genus Pneumovirus". In Kingsbury, David W. (ed.). The Paramyxoviruses. The Viruses. pp. 103–62. doi:10.1007/978-1-4615-3790-8_4. ISBN   978-1-4613-6689-8.